Streptozocin, also known as streptozotocin or STZ, is a naturally occurring chemical that is part of the nitrosourea family of compounds. It was first identified in the late 1950s from the bacterium Streptomyces achromogenes. Since its discovery, streptozocin has found a niche both in medical treatment, particularly in the management of
pancreatic cancers, and in scientific research, especially in the study of
diabetes. Understanding the mechanism of streptozocin involves delving into its chemical properties, its interactions with cellular components, and its ultimate effects on biological systems.
Chemically, streptozocin is a glucosamine-nitrosourea compound, which means it combines a sugar molecule (glucosamine) with a nitrosourea moiety. This unique structure is pivotal to its function. The sugar component allows streptozocin to be selectively taken up by pancreatic beta cells, which play a crucial role in insulin production.
Once inside the pancreatic beta cells, streptozocin undergoes a series of chemical reactions that lead to its cytotoxic effects. The nitrosourea component of streptozocin is highly reactive and can alkylate DNA. Alkylation is the process by which an alkyl group is transferred to DNA molecules, leading to the formation of DNA adducts. These adducts can cause various types of DNA damage, including single-strand breaks, double-strand breaks, and crosslinking of DNA strands.
The DNA damage induced by streptozocin triggers a cascade of cellular responses. One of the primary responses is the activation of poly (ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair. While
PARP attempts to repair the DNA damage, its excessive activation depletes cellular stores of NAD+ and ATP, which are essential for cellular energy metabolism. The depletion of these molecules leads to energy crisis and ultimately cell death through a process known as necrosis.
Additionally, streptozocin-induced DNA damage can activate
p53, a
tumor suppressor protein that plays a key role in regulating the cell cycle and apoptosis. When activated, p53 can lead to cell cycle arrest, allowing the cell time to repair the DNA. However, if the DNA damage is too extensive, p53 can trigger apoptosis, a programmed cell death mechanism.
In the context of pancreatic cancer treatment, the selective uptake of streptozocin by pancreatic beta cells is highly beneficial.
Pancreatic islet tumors, particularly
insulinomas, are comprised predominantly of beta cells. Streptozocin's ability to target these cells makes it an effective chemotherapeutic agent for these types of tumors. By inducing DNA damage and subsequent cell death in the tumor cells, streptozocin helps to reduce tumor size and alleviate symptoms associated with excessive insulin production.
In addition to its use in cancer therapy, streptozocin has been widely used in scientific research to induce experimental diabetes in animal models. The selective destruction of pancreatic beta cells by streptozocin mimics the beta cell loss seen in both Type 1 and
Type 2 diabetes. This allows researchers to study the mechanisms of diabetes development and to test potential therapeutic interventions in a controlled setting.
Despite its therapeutic benefits, streptozocin has several side effects that limit its use. The most notable side effects include
nephrotoxicity (kidney damage), hepatotoxicity (liver damage), and gastrointestinal disturbances. These adverse effects are thought to result from the non-selective action of streptozocin on other tissues and organs, necessitating careful monitoring and dose adjustments during treatment.
In summary, the mechanism of streptozocin involves its selective uptake by pancreatic beta cells, subsequent DNA alkylation, and induction of DNA damage leading to cell death. This mechanism underpins its use in the treatment of pancreatic islet cell tumors and its application in diabetes research. However, its therapeutic use is tempered by significant side effects, highlighting the need for ongoing research to optimize its efficacy and safety.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


